JPRN-UMIN000053072CompletedUnknown
Immune Persistence and Safety Cohort Survey on Booster vaccination of the Newly developed SARS-CoV-2 Omicron Strain XBB.1.5 Vaccine in Japan - Immune Persistence and Safety Cohort Survey on Booster Vaccination the New SARS-CoV-2 Vaccine in Japan
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Completed
- Sponsor
- Juntendo University
- Enrollment
- 300
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 12years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Those who are inappropriate as the subject of the survey determined by the principal investigator
Investigators
Similar Trials
Completed
Unknown
Immune Persistence and Safety Survey (Cohort Survey) related to the Bivalent SARS-CoV-2 Booster Vaccination in JapaCOVID-19JPRN-UMIN000049533Juntendo University2,848
Completed
Not Applicable
Immune Persistence and Safety Survey (Cohort Survey) related to the SARS-CoV-2 Booster Vaccination (4th dose) in JapaCOVID-19JPRN-UMIN000047919Juntendo University3,441
Completed
Unknown
Immune Persistence and Safety Survey regarding Initial and Booster Vaccination of Monovalent Vaccine for SARS-CoV-2 Omicron Strain XBB.1.5 (Cohort Study) in JapaCOVID-19JPRN-UMIN000052238Juntendo University3,391
Completed
Not Applicable
Immune persistence and safety survey (cohort survey) related to the first series of new corona recombinant protein vaccines and boostersCOVID-19JPRN-UMIN000047920Juntendo University579
Not yet recruiting
Phase 4
A clinical study to evaluate Immunity Booster Capules for boosting immunityCTRI/2020/10/028775Amitojas Wellness Private Limited